mHealth Market - Global Forecast 2025-2032

The mobile health (mHealth) market presents sustained growth driven by the increasing adoption of connected devices, advanced data analytics, and patient-focused applications, resulting in enhanced engagement and efficiency across the global healthcare landscape. Senior executives seeking to capitalize on mHealth now face both expansive opportunities and intricate operational challenges.

Market Snapshot: mHealth Market Growth and Dynamics

The mHealth market grew from USD 94.82 billion in 2024 to USD 109.36 billion in 2025. It is projected to expand at a CAGR of 16.17%, reaching USD 314.55 billion by 2032. This robust growth is fueled by widespread device integration, regulatory momentum favoring digital health, and the strategic demands of value-based care. As a result, mHealth is evolving from an emerging segment into a core enabler of healthcare transformation for organizations across regions.

Scope & Segmentation: Unpacking the mHealth Ecosystem

• Connected Medical Devices: Blood glucose meters, blood pressure monitors, ECG/heart rate monitors, fetal monitoring devices, neurological monitoring devices, peak flowmeters, pulse oximeters, and sleep apnea monitors are critical components delivering real-time biometric monitoring and actionable insights.
• mHealth Apps: Solutions for chronic disease management, blood pressure and ECG monitoring, cancer and diabetes management, mental and obesity health, medication management, personal health records, menstrual health, and pregnancy tracking are integral to continuous patient engagement.
• mHealth Services: Diagnosis and consultation, fitness and wellness guidance, preventive screenings, remote monitoring, and treatment support services provide comprehensive care delivery outside traditional clinical settings.
• Wearable Devices: Fitness trackers and smartwatches facilitate active lifestyle management and support long-term health objectives.
• Applications: Chronic disease management, general health and fitness, remote telemedicine, menopause management, and reproductive health are key focus areas for precision interventions.
• End-User Segments: Healthcare payers, clinics, hospitals, and patients all collaborate within a networked digital health ecosystem, shaping both innovation and adoption priorities.
• Geographies: Segmentation covers the Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland), Middle East (United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel), Africa (South Africa, Nigeria, Egypt, Kenya), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
• Industry Players: Key contributors include AgaMatrix, AirStrip Technologies, Akili Interactive Labs, AliveCor, Amazon Web Services, Apple, AT&T, Biofourmis, Boston Scientific, Cisco Systems, Cognoa, eMed Healthcare UK, Google (Alphabet), iHealth Lab, IBM, Johnson & Johnson, Philips, Lumeon, Medtronic, OMRON Healthcare, Oracle, Qualcomm, Samsung Electronics, among others.

Key Takeaways for Strategic Decision-Makers

• mHealth accelerates the delivery of patient-centered care by connecting patients, providers, and payers through digital interfaces for real-time engagement and actionable insights.
• Healthcare organizations must strategically prioritize integrated platforms and omnichannel solutions to support continuity of care and meet rising consumer expectations.
• Collaboration between established device manufacturers, digital innovators, and health systems is now critical for product development, rapid scaling, and patient adoption.
• The evolving regulatory and reimbursement environment is driving greater acceptance of digital health solutions, supporting investment in technology-driven operational models.
• End-user engagement is underpinned by user-focused design, AI-powered personalization, and proactive health interventions tailored to distinct patient populations.

Tariff Impact: Navigating Regulatory and Trade Complexities

Changes to United States tariffs in 2025 have increased costs within the global mHealth supply chain. Manufacturers and distributors are now implementing strategies such as near-shoring and dual-sourcing to offset risks. Large health systems are renegotiating contracts and evaluating device procurement to manage higher acquisition costs. Meanwhile, logistics innovation and collaboration with tariff advisory services have become essential for ensuring reliable distribution and cost control.

Methodology & Data Sources

This report integrates primary and secondary data sources, including executive interviews, clinical expert consultations, and comprehensive reviews of regulatory and industry reports. Analytical frameworks and data triangulation ensure the findings are accurate, robust, and evidence-based.

Why This Report Matters

• Offers clear guidance to develop competitive strategies for expanding digital health portfolios and improving care delivery models.
• Enables healthcare leaders to anticipate supply chain disruptions and regulatory shifts, promoting operational agility and sustained value creation.

Conclusion

The mHealth market is reshaping healthcare through innovation, integration, and intensified collaboration. Informed investment and proactive strategy will define leadership in digital health for years ahead.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.